Company / Cost of Revenue
CONMED Corporation Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$624.2M
FY2025
5-year range
$402.2M / $624.2M
FY2021-FY2025
Trend
+8.8%
vs FY2024
Sector context
#57 of 113
Health Care
What the data says
At $624M, CONMED Corporation's cost of revenue ranks #57 of 113 in the Health Care sector. Cost of Revenue has increased for 3 consecutive years, from $402M in FY2022 to $624M in FY2025.
Based on SEC 10-K filings.
$624M in FY2025 with a 5-year CAGR of +9.8%.
Increased from $568M to $624M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +15.8%
- 5-Year CAGR
- +9.8%
- 10-Year CAGR
- -
Sector benchmark
#57 of 113 in Health CareTop 50% of 113This company $624.2M Sector average $11.3B
▼
-94.5% below sector average
Key checks
Key Insights
- CONMED Corporation's cost of revenue has grown for 3 consecutive years.
- 5-year CAGR of +9.8%, indicating consistent growth.
- In FY2025, cost of revenue increased 8.8% year-over-year.
- Ranks #57 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $624.2M | +8.8% |
| FY2024 | $574.0M | +1.0% |
| FY2023 | $568.5M | +41.4% |
| FY2022 | $402.2M | -6.6% |
| FY2021 | $430.4M | +10.2% |
| FY2020 | $390.5M | +6.9% |
| FY2019 | $365.4M | +2.9% |
| FY2018 | $355.2M | +5.3% |
| FY2017 | $337.5M | +0.4% |
| FY2016 | $336.0M | -0.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026